Xu Shuwen, Koldovsky Ursula, Xu Min, Wang Daniel, Fitzpatrick Elizabeth, Son Gilsoo, Koski Gary, Czerniecki Brian J
Harrison Department of Surgical Research, University of Pennsylvania, Philadelphia, PA, USA.
Surgery. 2006 Aug;140(2):170-8. doi: 10.1016/j.surg.2006.03.006.
High-level production of heterodimeric p70 interleukin (IL)-12 by myeloid-derived dendritic cells (DCs) requires 2 signals: interferon gamma (IFN-gamma) and a maturation signal provided by CD40 ligation (CD40L) or lipopolysaccharide (LPS).
In the current study we demonstrate that signaling through toll-like receptor (TLR) 8, but not TLR3, TLR2, or TLR4, provides a priming signal to myeloid-derived DC for high IL-12 p70 heterodimer production.
All the TLR agonists induced maturation of DC as evidenced by increased expression of CD83, CD80, and CD86. Both IFN-gamma and TLR7/8 agonist R848 increased expression of TLR8 in immature monocyte-derived DCs. The combination of TLR7/8 agonist R848 and maturation signals LPS or CD40L induced high-level expression of IL-12p35 and p40 similar to that induced by IFN-gamma plus LPS. In contrast, receptor agonists specific for TLR7 did not prime for IL-12 production. The p70 IL-12 produced by the TLR8-primed DC polarized CD4+ T for Th1 cytokine production and induced CD8+ T cells, displaying high functional avidity with enhanced tumor cell recognition.
The data suggest that toll 8 receptor agonists are useful for inducing type-1 polarized DCs for vaccine design in treating cancer and infectious disease.
髓样来源的树突状细胞(DCs)高水平产生异源二聚体p70白细胞介素(IL)-12需要两个信号:干扰素γ(IFN-γ)以及由CD40配体(CD40L)或脂多糖(LPS)提供的成熟信号。
在本研究中,我们证明通过Toll样受体(TLR)8而非TLR3、TLR2或TLR4发出的信号,为髓样来源的DC提供了引发信号,以产生高IL-12 p70异源二聚体。
所有TLR激动剂均诱导DC成熟,表现为CD83、CD80和CD86表达增加。IFN-γ和TLR7/8激动剂R848均增加未成熟单核细胞来源DC中TLR8的表达。TLR7/8激动剂R848与成熟信号LPS或CD40L的组合诱导IL-12p35和p40的高水平表达,类似于IFN-γ加LPS诱导的表达。相比之下,TLR7特异性受体激动剂不能引发IL-12的产生。由TLR8引发的DC产生的p70 IL-12使CD4 + T细胞向Th1细胞因子产生极化,并诱导CD8 + T细胞,其表现出高功能亲和力并增强肿瘤细胞识别。
数据表明,Toll 8受体激动剂可用于诱导1型极化DC,用于癌症和传染病治疗的疫苗设计。